CJC-1295 is an analogue of growth hormone releasing hormone (GHRH). The DAC version carries a Drug Affinity Complex, which binds the peptide to blood albumin and extends its half-life from minutes to several days – the practical difference between CJC-1295 DAC and the shorter-acting Mod GRF 1-29 form.
This pack contains one vial holding 5 mg of CJC-1295 DAC as a dry powder, requiring reconstitution before use.
Key Benefits
- GHRH analogue studied for its effect on the body’s own growth hormone pulses
- DAC modification gives a substantially longer duration of action than unmodified fragments
- Commonly studied alongside ghrelin-mimetic peptides such as Ipamorelin
- Supplied as a 5 mg multi-dose vial of lyophilised powder
Instructions
- Reconstitution: mix with bacteriostatic water or sodium chloride solution, swirl gently (do not shake)
- Administration: subcutaneous injection, per the vial labelling
- Dosage and cycle length: follow the guidance supplied with your order
Side Effects & Warnings
- Not an approved medicine in the EU; sold for research purposes
- Prohibited in competitive sport under WADA rules
- Water retention, tingling or flushing are commonly reported with GH-axis peptides
- Should only be used after consulting a qualified healthcare professional
- Not evaluated for use by minors, or during pregnancy or breastfeeding
Storage
Store the unmixed vial refrigerated at 2-8 °C, and keep the reconstituted solution refrigerated as well, using it within the recommended timeframe after mixing. For subcutaneous use only.
Reviews
There are no reviews yet